{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:19:05Z","timestamp":1784697545189,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpba.2025.116879","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:22:31Z","timestamp":1744118551000},"page":"116879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Alcohol-based solvents as mobile phases for LC-MS characterization of therapeutic proteins"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9953-164X","authenticated-orcid":false,"given":"Mostafa","family":"Zarei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Jonveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116879_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.trac.2010.03.008","article-title":"Greening analytical chromatography","volume":"29","author":"Welch","year":"2010","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116879_bib2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1039\/C8GC03875A","article-title":"Making the move towards modernized greener separations: introduction of the analytical method greenness score (AMGS) calculator","volume":"21","author":"Hicks","year":"2019","journal-title":"Green. Chem."},{"key":"10.1016\/j.jpba.2025.116879_bib3","first-page":"4","article-title":"Eco-friendly RP-HPLC - Replacing acetonitrile with Isopropanol in analytical and purification utilising core-shell chromatography","volume":"47","author":"Reilly","year":"2022","journal-title":"Int. LABMATE"},{"key":"10.1016\/j.jpba.2025.116879_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/abio.1998.2919","article-title":"Sample preparation for peptide mapping - A pharmaceutical quality-control perspective","volume":"266","author":"Lundell","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2025.116879_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mas.20190","article-title":"Mass spectrometry for structural characterization of therapeutic antibodies","volume":"28","author":"Zhang","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jpba.2025.116879_bib6","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1074\/mcp.R120.002234","article-title":"Single-cell proteomics: progress and prospects","volume":"19","author":"Kelly","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.jpba.2025.116879_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/acs.jproteome.2c00388","article-title":"Acetic acid ion pairing additive for reversed-phase HPLC improves detection sensitivity in bottom-up proteomics compared to formic acid","volume":"22","author":"Battellino","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2025.116879_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4155\/bio.10.76","article-title":"Bioanalytical solutions to acetonitrile shortages","volume":"2","author":"Gao","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.116879_bib9","first-page":"1","article-title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Impurities: Q3C \u2014 Tables and List, Guidance for Industry (Revision 4)","year":"2018","journal-title":"FDA"},{"key":"10.1016\/j.jpba.2025.116879_bib10","first-page":"488","article-title":"Detoxification of acetonitrile-water wastes from liquid chromatography","volume":"41","author":"Gilomen","year":"1995","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2025.116879_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/molecules23051065","article-title":"Greening reversed-phase liquid chromatography methods using alternative solvents for pharmaceutical analysis","volume":"23","author":"Yabr\u00e9","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2025.116879_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jchromb.2010.01.029","article-title":"Replacement of acetonitrile by ethanol as solvent in reversed phase chromatography of biomolecules","volume":"878","author":"Brettschneider","year":"2010","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2025.116879_bib13","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.3390\/molecules29133205","article-title":"Enhancing sustainable analytical chemistry in liquid chromatography: guideline for transferring classical high-performance liquid chromatography and ultra-high-pressure liquid chromatography methods into greener, bluer, and whiter methods","volume":"29","author":"El Deeb","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2025.116879_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.chroma.2014.02.048","article-title":"Solvent selectivity and strength in reversed-phase liquid chromatography separation of peptides","volume":"1337","author":"Gilar","year":"2014","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2025.116879_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.chroma.2006.01.016","article-title":"Optimization of a reversed-phase high-performance liquid chromatography\/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability","volume":"1120","author":"Dillon","year":"2006","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2025.116879_bib16","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3390\/pharmaceutics14112315","article-title":"Ultra-fast middle-up reversed phase liquid chromatography analysis of complex bispecific antibodies obtained in less than one minute","volume":"14","author":"Murisier","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2025.116879_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/1044-0305(94)85050-X","article-title":"Characterization of protein iv-glycosylation by reversed-phase microbore liquid chromatography \/ electrospray mass spectrometry, complementary mobile phases, and sequential exoglycosidase digestion","volume":"5","author":"Medzihradszky","year":"1994","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116879_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/(SICI)1097-0231(19980430)12:8<472::AID-RCM182>3.0.CO;2-H","article-title":"Reverse-phase capillary high performance liquid chromatography\/high performance electrospray ionization mass spectrometry: an essential tool for the characterization of complex glycoprotein digests","volume":"12","author":"Medzihradszky","year":"1998","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116879_bib19","doi-asserted-by":"crossref","first-page":"36825","DOI":"10.1021\/acsomega.2c05325","article-title":"Proteomic analysis of adenovirus 5 by UHPLC-MS\/MS: development of a robust and reproducible sample preparation workflow","volume":"7","author":"Zarei","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2025.116879_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jproteome.0c00479","article-title":"Sense and nonsense of elevated column temperature in proteomic bottom-up LC-MS analyses","volume":"20","author":"Lenco","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2025.116879_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0021-9673(00)85732-5","article-title":"Classification of the solvent properties of common liquids","volume":"92","author":"Snyder","year":"1974","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2025.116879_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/chromsci\/16.6.223","article-title":"Classification off the solvent properties of common liquids","volume":"16","author":"Snyder","year":"1978","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2025.116879_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0021-9673(01)94407-3","article-title":"Eluotropic strength of solvents: prediction and use in reversed-phase high-performance liquid chromatography","volume":"389","author":"Patel","year":"1987","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2025.116879_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S1044-0305(03)00128-4","article-title":"Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI?","volume":"14","author":"Schmidt","year":"2003","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116879_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/aic.690010222","article-title":"Correlation of diffusion coefficients in dilute solutions","volume":"1","author":"Wilke","year":"1955","journal-title":"AICHE J."},{"key":"10.1016\/j.jpba.2025.116879_bib26","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1021\/ac100359p","article-title":"Quantitative improvements in peptide recovery at elevated chromatographic temperatures from microcapillary liquid chromatography-mass spectrometry analyses of brain using selected reaction monitoring","volume":"82","author":"Farias","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116879_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antib8010018","article-title":"Macro- and micro-heterogeneity of natural and recombinant IgG antibodies","volume":"8","author":"Beck","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.jpba.2025.116879_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biologicals.2019.03.006","article-title":"Modifications of recombinant monoclonal antibodies in vivo","volume":"59","author":"Liu","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.jpba.2025.116879_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/ac901931c","article-title":"Utility of retention prediction model for investigation of peptide separation selectivity in reversed-phase liquid chromatography: impact of concentration of trifluoroacetic acid, column temperature, gradient slope and type of stationary phase","volume":"82","author":"Gilar","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116879_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.xphs.2021.11.024","article-title":"Oxidation and deamidation of monoclonal antibody products: potential impact on stability, biological activity, and efficacy","volume":"111","author":"Gupta","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.116879_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4161\/mabs.2.3.11755","article-title":"Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymes","volume":"2","author":"Khor","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2025.116879_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4161\/mabs.21328","article-title":"Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies","volume":"4","author":"Du","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2025.116879_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jasms.2006.08.008","article-title":"Quantitating the relative abundance of isoaspartyl residues in deamidated proteins by electron capture dissociation","volume":"18","author":"Cournoyer","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116879_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/19420862.2018.1548233","article-title":"Deamidation and isomerization liability analysis of 131 clinical-stage antibodies","volume":"11","author":"Lu","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2025.116879_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphar.2014.00087","article-title":"Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies","volume":"5","author":"Eakin","year":"2014","journal-title":"Front. Pharm."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T20:20:35Z","timestamp":1753388435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"alternative-id":["S0731708525002201"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116879","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol-based solvents as mobile phases for LC-MS characterization of therapeutic proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116879"}}